The roundup is formatted with the title of the story, followed by the news source in parentheses and a brief summary. If you find a particularly interesting article, please send it to firstname.lastname@example.org for inclusion in next week’s roundup.
ASBMB making news:
Toward a sustainable biomedical research enterprise: Finding consensus and implementing recommendations (PNAS) The ASBMB published a paper delivering 8 consensus recommendations to make the biomedical research enterprise more sustainable.
Society asks NIH to act now to lessen biomed scientist glut (Science Insider)
Chris Pickett, lead author and science policy analyst for ASBMB, published a series of blogs to discuss the need to write such a paper, explain the importance of coordinated implementation of the recommendations, and look more closely at issues which require more discussion.
Toward a sustainable biomedical research enterprise: An author’s perspective (ASBMB Policy Blotter)
Toward a sustainable biomedical research enterprise: More work required (ASBMB Policy Blotter)
In other news:
Senator offers tantalizing prospect of regulatory relief for biomedical researchers (Science Insider) Sen. Lamar Alexander, R-Tenn., urged the National Academy of Sciences panel investigating federal oversight of academic research to deliver their recommendations ahead of schedule.
Congress Must Clear the Bureaucratic Underbrush on the Journey to Life-Saving Genomic Medicine (Roll Call) President Obama’s Precision Medicine Initiative faces obstacles that can be overcome with privacy reform, interoperability between researchers and health care providers, and health care consumer buy in.
New ‘TripAdvisor’ site to address use of substandard biomedical research tools (EurekAlert!) New web-based portal will crowd source chemical probes.
Why the diseases that cause the most harm don’t always get the most research money (The Washington Post) Recently the National Institutes of Health published a report detailing how it allocates funding to specific diseases compared to the burden of those diseases in the United States.